Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
The European Society of Cardiology (ESC) 2016 annual congress will take place from Saturday, August 27 through Wednesday, August 31 in Rome, Italy.
For this year’s Congress Spotlight, ESC and its related organizations developed “The Heart Team,” which will underscore the importance of collaboration among healthcare professionals of all different specialties who manage and treat patients with cardiovascular disease.
In addition, 3 new tracks in surgery, stroke, and e-cardiology will be presented. The surgeon track will help bridge the gap between cardiology and cardiac surgery. The stroke track will highlight cardiac issues in stroke including catheter-based therapy of acute stroke and collaboration between neurologists and cardiologists. Finally, the e-cardiology track will highlight technological developments that are improving quality of care, including remote monitoring of implantable devices and e-Health applications in heart failure.
The Gladiators Arena—a twist on the conventional panel discussion—will feature “debates” between key opinion leaders on current issues in the field, and allow the audience to vote for the best argument. Topics include: ventricular tachycardia ablation, thromboembolic prevention after transcatheter aortic valve replacement, and stable ischemic heart disease in women.
ESC 2016 Highlights (by day)
Sunday, August 28
Hot Lines
DANISH–A Danish randomized, controlled, multicenter study to assess the effect on mortality of implantable cardioverter defibrillators in patients with nonischemic systolic heart failure
MORE-CARE—Effects of remote monitoring on outcomes and use of healthcare resources in patients with heart failure and implanted biventricular defibrillators
ANTARCTIC—Platelet function monitoring in elderly patients post-stent placement for an acute coronary syndrome
Clinical Trial Updates
ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial), ACCELERATE (Lipid Levels and CV Outcome with CETP Inhibition by Evacetrapib)
IMPROVE-IT (Benefit of Adding Ezetimibe to Statin Therapy in Patients With or Without Prior Coronary Artery Bypass Graft Surgery)
Monday, August 29
Hot Lines
OPTICARE—Benefits of the Optimal Cardiac Rehabilitation trial: a randomized, controlled superiority trial of an expanded educational and behavioral intervention
ESCAPE—Effect of alirocumab on the frequency of lipoprotein apheresis: a randomized, phase 3 trial
AMERICA—Systematic detection and management of multivascular involvement of atherothrombosis in coronary patients compared with treatment of coronary disease only
Clinical Trial Updates
EMPA-REG OUTCOME trial (Effects of Empagliflozin on Cardiovascular Mortality by Prevalent or Incident Heart Failure and Effects of Empagliflozin on Overall Heart Failure Burden
FRISC II study, 15-year follow-up (A Lifetime Perspective on the Effects of an Early Invasive Compared With a Non-Invasive Treatment Strategy in Patients With Non-ST-Elevation Acute Coronary Syndrome)
ABSORB Japan trial (2-Year Clinical Results from a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions)
Tuesday, August 30
Hot Lines
ANNEXA-4—Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding
ENSURE-AF—Edoxaban for cardioversion of atrial fibrillation
Clinical Trial Updates
PEGASUS-TIMI 54 trial (Prevention of First Stroke With Ticagrelor in Patients With Prior Myocardial Infarction)
LEADERS FREE substudy (PCI for Elderly Patients at High Bleeding Risk)
Reference
European Society of Cardiology. ESC Congress. August 27-31, 2016; Rome, Italy. http://www.escardio.org/Congresses-%26-Events/ESC-Congress. August 26, 2016.
